Screening and diagnosis of pulmonary hypertension associated with chronic lung disease (PH‐CLD): A consensus statement from the pulmonary vascular research institute's innovative drug development initiative—group 3 pulmonary hypertension

Ähnliche Einträge

• Pulmonary hypertension in the setting of interstitial lung disease: Approach to management and treatment. A consensus statement from the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative—Group 3 Pulmonary Hypertension
  von: Oksana A. Shlobin, et al.
  Veröffentlicht: (2024)
• Pulmonary vascular dysfunction without pulmonary hypertension: A distinct phenotype in idiopathic pulmonary fibrosis
  von: Steven D. Nathan, et al.
  Veröffentlicht: (2024)
• Balloon pulmonary angioplasty for chronic thromboembolic pulmonary disease without pulmonary hypertension
  von: Takatoyo Kiko, et al.
  Veröffentlicht: (2024)
• Predictors of early mortality after lung transplantation for idiopathic pulmonary arterial hypertension
  von: Reda E. Girgis, et al.
  Veröffentlicht: (2024)
• Nationwide trends of balloon pulmonary angioplasty and pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension (2012–2019)
  von: Adam S. Vohra, et al.
  Veröffentlicht: (2024)